PRISM

oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery a Read More

Classification Information

Class [5]
Pharmaceutical Products

Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for use in targeted gene silencing; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies.

Class [40]
Treatment & Processing of Materials Services

Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders.

Class [42]
Computer & Software Services & Scientific Services

Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing.

Mark Details

Serial Number

UK00918097986

Mark Type

Figurative

Kind of mark

Individual